|
|
Article: New Data on the Clinical Performance of the CYPHER Stent In Long Lesions, Diabetics and Other Complex Cases to Be Presented at TCT 2004.
- Article from:
- PR Newswire
- Article date:
- September 24, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MIAMI, Sept. 24 /PRNewswire/ -- The body of clinical evidence for the CYPHER(R) Sirolimus-eluting Coronary Stent continues to grow as new data from around the world are presented at the Cardiovascular Research Foundation's (CRF) Sixteenth Annual Scientific Symposium, Transcatheter Cardiovascular Therapeutics (TCT 2004), during the week of September 27th in Washington, DC.
More than 200 presentations, abstracts and posters examine the CYPHER Stent, which remains the most studied drug-eluting stent available today. Among the key CYPHER Stent presentations at the international medical conference are a head-to-head drug-eluting stent study that will provide ...